AS
Alok Srivastava
About Alok Srivastava
Data last updated:
Alok Srivastava was a Director at Advanced Medicinal Therapies Foundation (Amtf) (2022–2024) and Director at Advanced Transfusion Medicine Research Foundation (2001–2012). The companies operate in Research & Development and Healthcare.
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Advanced Medicinal Therapies Foundation (Amtf) U73100TN2022NPL150690 | Director | 22 Mar 2022 | 2022 | ₹9 Lakh (FY 2025) | Active |
 Advanced Transfusion Medicine Research Foundation U19129GJ1997NPL032264 | Director | 13 Mar 2001 | 1997 | ₹7.50 Cr (FY 2022) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Alok Srivastava
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Alok Srivastava
Alok Srivastava was first appointed on 13 Mar 2001 as Director at Advanced Transfusion Medicine Research Foundation. The most recent appointment on record is 22 Mar 2022 at Advanced Medicinal Therapies Foundation (Amtf).
Alok Srivastava held 2 earlier board appointments: Advanced Medicinal Therapies Foundation (Amtf) (Director, 22 Mar 2022 to 20 Aug 2024); Advanced Transfusion Medicine Research Foundation (Director, 13 Mar 2001 to 31 Jan 2012).